Yi-Hsin Chan1, Wei-Chung Tsai1, Jum-Suk Ko1, Dechun Yin1, Po-Cheng Chang1, Michael Rubart1, James N Weiss1, Thomas H Everett1, Shien-Fong Lin1, Peng-Sheng Chen2. 1. From Krannert Institute of Cardiology and Division of Cardiology, Department of Medicine (Y.-H.C., W.-C.T., P.-C.C., T.H.E., S.-F.L., P.-S.C.) and Wells Center for Pediatrics Research, Department of Pediatrics (M.R.), Indiana University School of Medicine, Indianapolis; Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Linkou, Taoyuan, Taiwan (Y.-H.C., P.-C.C.); Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung University College of Medicine, Taiwan (W.-C.T.); Division of Cardiology, Department of Internal Medicine, Wonkwang University School of Medicine and Hospital, Jeonbuk, Republic of Korea (J.-S.K.); Department of Cardiology, First Affiliated Hospital of Harbin Medical University, China (D.Y.); Departments of Medicine (Cardiology) and Physiology, University of California, Los Angeles (J.N.W.); and Institute of Biomedical Engineering, National Chiao-Tung University, Hsin-Chu, Taiwan (S.-F.L.). 2. From Krannert Institute of Cardiology and Division of Cardiology, Department of Medicine (Y.-H.C., W.-C.T., P.-C.C., T.H.E., S.-F.L., P.-S.C.) and Wells Center for Pediatrics Research, Department of Pediatrics (M.R.), Indiana University School of Medicine, Indianapolis; Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Linkou, Taoyuan, Taiwan (Y.-H.C., P.-C.C.); Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung University College of Medicine, Taiwan (W.-C.T.); Division of Cardiology, Department of Internal Medicine, Wonkwang University School of Medicine and Hospital, Jeonbuk, Republic of Korea (J.-S.K.); Department of Cardiology, First Affiliated Hospital of Harbin Medical University, China (D.Y.); Departments of Medicine (Cardiology) and Physiology, University of California, Los Angeles (J.N.W.); and Institute of Biomedical Engineering, National Chiao-Tung University, Hsin-Chu, Taiwan (S.-F.L.). chenpp@iu.edu.
Abstract
BACKGROUND: Hypokalemia increases the vulnerability to ventricular fibrillation. We hypothesize that the apamin-sensitive small-conductance calcium-activated potassium current (IKAS) is activated during hypokalemia and that IKAS blockade is proarrhythmic. METHODS AND RESULTS: Optical mapping was performed in 23 Langendorff-perfused rabbit ventricles with atrioventricular block and either right or left ventricular pacing during normokalemia or hypokalemia. Apamin prolonged the action potential duration (APD) measured to 80% repolarization (APD80) by 26 milliseconds (95% confidence interval [CI], 14-37) during normokalemia and by 54 milliseconds (95% CI, 40-68) during hypokalemia (P=0.01) at a 1000-millisecond pacing cycle length. In hypokalemic ventricles, apamin increased the maximal slope of APD restitution, the pacing cycle length threshold of APD alternans, the pacing cycle length for wave-break induction, and the area of spatially discordant APD alternans. Apamin significantly facilitated the induction of sustained ventricular fibrillation (from 3 of 9 hearts to 9 of 9 hearts; P=0.009). Short-term cardiac memory was assessed by the slope of APD80 versus activation time. The slope increased from 0.01 (95% CI, -0.09 to 0.12) at baseline to 0.34 (95% CI, 0.23-0.44) after apamin (P<0.001) during right ventricular pacing and from 0.07 (95% CI, -0.05 to 0.20) to 0.54 (95% CI, 0.06-1.03) after apamin infusion (P=0.045) during left ventricular pacing. Patch-clamp studies confirmed increased IKAS in isolated rabbit ventricular myocytes during hypokalemia (P=0.038). CONCLUSIONS: Hypokalemia activates IKAS to shorten APD and maintain repolarization reserve at late activation sites during ventricular pacing. IKAS blockade prominently lengthens the APD at late activation sites and facilitates ventricular fibrillation induction.
BACKGROUND:Hypokalemia increases the vulnerability to ventricular fibrillation. We hypothesize that the apamin-sensitive small-conductance calcium-activated potassium current (IKAS) is activated during hypokalemia and that IKAS blockade is proarrhythmic. METHODS AND RESULTS: Optical mapping was performed in 23 Langendorff-perfused rabbit ventricles with atrioventricular block and either right or left ventricular pacing during normokalemia or hypokalemia. Apamin prolonged the action potential duration (APD) measured to 80% repolarization (APD80) by 26 milliseconds (95% confidence interval [CI], 14-37) during normokalemia and by 54 milliseconds (95% CI, 40-68) during hypokalemia (P=0.01) at a 1000-millisecond pacing cycle length. In hypokalemic ventricles, apamin increased the maximal slope of APD restitution, the pacing cycle length threshold of APD alternans, the pacing cycle length for wave-break induction, and the area of spatially discordant APD alternans. Apamin significantly facilitated the induction of sustained ventricular fibrillation (from 3 of 9 hearts to 9 of 9 hearts; P=0.009). Short-term cardiac memory was assessed by the slope of APD80 versus activation time. The slope increased from 0.01 (95% CI, -0.09 to 0.12) at baseline to 0.34 (95% CI, 0.23-0.44) after apamin (P<0.001) during right ventricular pacing and from 0.07 (95% CI, -0.05 to 0.20) to 0.54 (95% CI, 0.06-1.03) after apamin infusion (P=0.045) during left ventricular pacing. Patch-clamp studies confirmed increased IKAS in isolated rabbit ventricular myocytes during hypokalemia (P=0.038). CONCLUSIONS:Hypokalemia activates IKAS to shorten APD and maintain repolarization reserve at late activation sites during ventricular pacing. IKAS blockade prominently lengthens the APD at late activation sites and facilitates ventricular fibrillation induction.
Authors: Ali Baher; Zhilin Qu; Ashkan Hayatdavoudi; Scott T Lamp; Ming-Jim Yang; Fagen Xie; Stephen Turner; Alan Garfinkel; James N Weiss Journal: Am J Physiol Heart Circ Physiol Date: 2006-08-04 Impact factor: 4.733
Authors: Norbert Nagy; Viktória Szuts; Zoltán Horváth; György Seprényi; Attila S Farkas; Károly Acsai; János Prorok; Miklós Bitay; Attila Kun; János Pataricza; Julius Gy Papp; Péter P Nánási; András Varró; András Tóth Journal: J Mol Cell Cardiol Date: 2009-07-24 Impact factor: 5.000
Authors: Mu Chen; Dong-Zhu Xu; Adonis Z Wu; Shuai Guo; Juyi Wan; Dechun Yin; Shien-Fong Lin; Zhenhui Chen; Michael Rubart-von der Lohe; Thomas H Everett; Zhilin Qu; James N Weiss; Peng-Sheng Chen Journal: JCI Insight Date: 2018-11-15
Authors: Juyi Wan; Mu Chen; Zhuo Wang; Thomas H Everett; Michael Rubart-von der Lohe; Changyu Shen; Zhilin Qu; James N Weiss; Penelope A Boyden; Peng-Sheng Chen Journal: Heart Rhythm Date: 2018-11-13 Impact factor: 6.343
Authors: Jum-Suk Ko; Shuai Guo; Jonathan Hassel; Patricia Celestino-Soper; Ty C Lynnes; James E Tisdale; James J Zheng; Stanley E Taylor; Tatiana Foroud; Michael D Murray; Richard J Kovacs; Xiaochun Li; Shien-Fong Lin; Zhenhui Chen; Matteo Vatta; Peng-Sheng Chen; Michael Rubart Journal: Am J Physiol Heart Circ Physiol Date: 2018-04-20 Impact factor: 4.733
Authors: Nipavan Chiamvimonvat; Ye Chen-Izu; Colleen E Clancy; Isabelle Deschenes; Dobromir Dobrev; Jordi Heijman; Leighton Izu; Zhilin Qu; Crystal M Ripplinger; Jamie I Vandenberg; James N Weiss; Gideon Koren; Tamas Banyasz; Eleonora Grandi; Michael C Sanguinetti; Donald M Bers; Jeanne M Nerbonne Journal: J Physiol Date: 2017-01-05 Impact factor: 5.182